Correlation Between Concurrent Technologies and Biotech Growth

Can any of the company-specific risk be diversified away by investing in both Concurrent Technologies and Biotech Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Concurrent Technologies and Biotech Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Concurrent Technologies Plc and The Biotech Growth, you can compare the effects of market volatilities on Concurrent Technologies and Biotech Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Concurrent Technologies with a short position of Biotech Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Concurrent Technologies and Biotech Growth.

Diversification Opportunities for Concurrent Technologies and Biotech Growth

0.27

Correlation Coefficient

Concurrent Technologies  Biotech Growth

Modest diversification

The 3 months correlation between Concurrent and Biotech is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Concurrent Technologies Plc and The Biotech Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotech Growth and Concurrent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Concurrent Technologies Plc are associated (or correlated) with Biotech Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotech Growth has no effect on the direction of Concurrent Technologies i.e., Concurrent Technologies and Biotech Growth go up and down completely randomly.

Pair Corralation between Concurrent Technologies and Biotech Growth

Assuming the 90 days trading horizon Concurrent Technologies Plc is expected to generate 1.32 times more return on investment than Biotech Growth. However, Concurrent Technologies is 1.32 times more volatile than The Biotech Growth. It trades about 0.11 of its potential returns per unit of risk. The Biotech Growth is currently generating about 0.09 per unit of risk. If you would invest  16,134  in Concurrent Technologies Plc on April 23, 2025 and sell it today you would earn a total of  2,466  from holding Concurrent Technologies Plc or generate 15.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Concurrent Technologies Plc  vs.  The Biotech Growth

Concurrent Technologies

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Concurrent Technologies Plc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Concurrent Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.

Biotech Growth

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in The Biotech Growth are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Biotech Growth may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Concurrent Technologies and Biotech Growth

The main advantage of trading using opposite Concurrent Technologies and Biotech Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Concurrent Technologies position performs unexpectedly, Biotech Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotech Growth will offset losses from the drop in Biotech Growth's long position.

The idea behind Concurrent Technologies Plc and The Biotech Growth pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.